Amendment of Pre-IND Studies of F1013 For Liver Failure Initiated In China And Update On Drug Pipeline Development へのコメント

Amendment of Pre-IND Studies of F1013 For Liver Failure Initiated In China And Update On Drug Pipeline Development へのコメント /english/information/news/1440/ 株式会社ジーエヌアイグループ公式Webサイト Mon, 20 Feb 2023 13:31:19 +0000 hourly 1 https://wordpress.org/?v=6.5.5